FEB 20, 2019 2:43 PM PST

Cocktail of Common Antibiotics Fights E. coli Infections

WRITTEN BY: Nouran Amin

Researchers at the Technical University of Denmark are working towards finding new methods for battling antibiotic resistant bacteria. Currently, many disease-causing bacteria retain resistant genes that protect them against antibiotic treatment. One such resistant gene, CTX-M-15, involves encoding the protein--extended spectrum beta-lactamase (ESBL) which leads to resistance in E. coli for urinary tract infections.

Learn more on antibiotic-resistant bacteria:

However, most recently researchers showed that a cocktail of two common antibiotics, mecillinam and cefotaxime, can result in specific multi-resistant E. coli (extended spectrum beta-lactamase, ESBL) sensitive to treatment again. Results of the cocktail antibiotics study was published in Nature and shows that bacteria resistant to mecillinam, were now sensitive to the drug cefotaxime and bacteria that had become resistant to cefotaxime were now sensitive towards mecillinam. These drugs could be administered orally -- as pills, making it easier for doctors to prescribe the already approved drugs to treat multi-drug resistant E. coli (ESBL) infections.

Image Credit: ZMESCIENCE.com

"The results are interesting because we showed that bacteria simply can't survive both drugs. Also, the same gene with only one mutation shows this switch-function. Normally, you will find multiple mutations in multiple resistance genes, controlling different mechanisms," says first-author Carola Rosenkilde, PhD-student at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at Technical University of Denmark (DTU). "We need to take precautionary measures to avoid resistance, because it is very likely that this mutation will occur at some point. By giving both mecillinam and cefotaxime at the same time, the CTX-M-15 mutation works like a switch, and the bacteria become sensitive to treatment again.”

Source: Technical University of Denmark

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
SEP 27, 2020
Cannabis Sciences
THC Shows Promise in Treating Severe Cases of COVID-19
SEP 27, 2020
THC Shows Promise in Treating Severe Cases of COVID-19
Over the last few months, various headlines have emerged suggesting the potential for cannabinoids, and in particular, c ...
NOV 11, 2020
Health & Medicine
A smart path for novel biologics
NOV 11, 2020
A smart path for novel biologics
Introduction  Cell culture is at the heart of the production process for many biopharmaceuticals, but finding the o ...
OCT 21, 2020
Drug Discovery & Development
New ALS Treatment Extends Life for Several Months
OCT 21, 2020
New ALS Treatment Extends Life for Several Months
Currently, there are only two approved medications to treat Lou Gehrig's disease (also known as ALS), a condition po ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
Loading Comments...